asimov.com

Webside score asimov.com

Asimov — Intelligent Design

 Genereret Marts 30 2026 15:19 PM

Gammel data? OPDATER !

Scoren er 56/100

SEO Indhold

Titel

Asimov — Intelligent Design

Længde : 27

Perfekt, din titel indeholder mellem 10 og 70 bogstaver.

Beskrivelse

Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.

Længde : 154

Perfekt, din meta beskrivelse indeholder mellem 70 og 160 karakterer.

Nøgleord

Dårligt! Vi kan ikke finde nogle meta nøgleord på din side! Brug denne gratis online meta generator for at oprette nye nøgleord.

Og Meta Egenskaber

Godt, din side benytter Og egenskaberne

Egenskab Indhold
type website

Overskrifter

H1 H2 H3 H4 H5 H6
1 87 80 0 0 0
  • [H1] Intelligent designof living systems
  • [H2] Enabling the design and manufacture of advanced therapies
  • [H2] Our approach
  • [H2] How to work with us
  • [H2] Two ways to work with us
  • [H2] Built by genetic designers, for biotech builders
  • [H2] Supported by top investors and US research agencies
  • [H2] Partnered with over 25 companies, from small biotechs to big pharma
  • [H2] In the press
  • [H2] Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
  • [H2] Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
  • [H2] Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
  • [H2] Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
  • [H2] Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
  • [H2] Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
  • [H2] Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
  • [H2] Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
  • [H2] Optimizing Bispecific Antibody Expression with Amgen
  • [H2] Optimizing Bispecific Antibody Expression with Amgen
  • [H2] Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
  • [H2] Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
  • [H2] Asimov Announces Cell Line Development Partnership with Ottimo Pharma to Accelerate Cancer Immunotherapy’s Path to Clinic
  • [H2] Asimov Announces Cell Line Development Partnership with Ottimo Pharma to Accelerate Cancer Immunotherapy’s Path to Clinic
  • [H2] Asimov Enters into Agreement with BARDA's BioMaP Consortium to Advance Production of Medical Countermeasures Against Ebola and Deadly Viruses
  • [H2] Asimov Enters into Agreement with BARDA's BioMaP Consortium to Advance Production of Medical Countermeasures Against Ebola and Deadly Viruses
  • [H2] Asimov Announces IND Approval and Clinical Dosing of Bispecific Antibody Produced Using CHO Edge Expression System
  • [H2] Asimov Announces IND Approval and Clinical Dosing of Bispecific Antibody Produced Using CHO Edge Expression System
  • [H2] Cytiva and Asimov collaborate on next generation cell line design and process development
  • [H2] Cytiva and Asimov collaborate on next generation cell line design and process development
  • [H2] LOTTE BIOLOGICS and Asimov Announce Partnership for Accelerated Cell Line Development And Scaling to GMP Manufacturing
  • [H2] LOTTE BIOLOGICS and Asimov Announce Partnership for Accelerated Cell Line Development And Scaling to GMP Manufacturing
  • [H2] Novo Nordisk license CHO Edge System
  • [H2] Novo Nordisk license CHO Edge System
  • [H2] Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
  • [H2] Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
  • [H2] Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
  • [H2] Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
  • [H2] Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
  • [H2] Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
  • [H2] Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
  • [H2] Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
  • [H2] Asimov launches LV Edge Packaging System to optimize lentivirus production
  • [H2] Asimov launches LV Edge Packaging System to optimize lentivirus production
  • [H2] Announcing Asimov Press
  • [H2] Announcing Asimov Press
  • [H2] Asimov Labs
  • [H2] Asimov Labs
  • [H2] Lift Off
  • [H2] Lift Off
  • [H2] Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
  • [H2] Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
  • [H2] Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
  • [H2] Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
  • [H2] Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
  • [H2] Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
  • [H2] Asimov Raises $200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology
  • [H2] Asimov Raises $200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology
  • [H2] Drug Manufacture Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200m To Fix It.
  • [H2] Drug Manufacture Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200m To Fix It.
  • [H2] Asimov Selected by DARPA to Develop Artificial Intelligence Design Engine for Synthetic Biology
  • [H2] Asimov Selected by DARPA to Develop Artificial Intelligence Design Engine for Synthetic Biology
  • [H2] MIT Startup Exchange Names Asimov to STEX25
  • [H2] MIT Startup Exchange Names Asimov to STEX25
  • [H2] MIT Spinout Asimov Implements Programming Language for Cells
  • [H2] MIT Spinout Asimov Implements Programming Language for Cells
  • [H2] How Programmable DNA Strands Could Control Healing
  • [H2] How Programmable DNA Strands Could Control Healing
  • [H2] The automatic-design tools that are changing synthetic biology
  • [H2] The automatic-design tools that are changing synthetic biology
  • [H2] Biologists would love to program cells as if they were computer chips
  • [H2] Biologists would love to program cells as if they were computer chips
  • [H2] How Cambridge Startup Asimov Is Doing Business With 'Genetic Circuits'
  • [H2] How Cambridge Startup Asimov Is Doing Business With 'Genetic Circuits'
  • [H2] Bio-programming toolkit maker Asimov launches with $4.7M from Andreessen Horowitz
  • [H2] Bio-programming toolkit maker Asimov launches with $4.7M from Andreessen Horowitz
  • [H2] Andreessen Horowitz Backs Asimov’s Synthetic Biology CAD Software
  • [H2] Andreessen Horowitz Backs Asimov’s Synthetic Biology CAD Software
  • [H2] Andreessen Horowitz leads seed round in MIT-born 'genetic circuits' startup
  • [H2] Andreessen Horowitz leads seed round in MIT-born 'genetic circuits' startup
  • [H2] Genetic Circuits Startup Asimov Raises Seed Round Led by Andreessen Horowitz
  • [H2] Genetic Circuits Startup Asimov Raises Seed Round Led by Andreessen Horowitz
  • [H2] Asimov
  • [H2] Asimov
  • [H2] Cellular Circuit Computes with DNA
  • [H2] Cellular Circuit Computes with DNA
  • [H2] A programming language for living cells
  • [H2] A programming language for living cells
  • [H2] We're hiring at the intersection of biology, engineering, and machine learning.
  • [H3] Biologics
  • [H3] Cell Therapies
  • [H3] Gene Therapies
  • [H3] Host cells
  • [H3] Genetic parts library
  • [H3] Design software
  • [H3] Host cell lines
  • [H3] Genetic parts library
  • [H3] Design software
  • [H3] We provide tools for you to develop a cell line
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We provide tools for you to develop a cell line
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We transfer our platform to your lab
  • [H3] We ship you host cells and grant software access
  • [H3] You design DNA
  • [H3] We ship DNA to you
  • [H3] You perform cell line development
  • [H3] We perform services in our lab
  • [H3] You request a stable cell line
  • [H3] We perform cell line and process development
  • [H3] We collaborate and share progress
  • [H3] We ship you clonal, stable cell lines
  • [H3] We provide tools for you to develop a cell line
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We transfer our platform to your lab
  • [H3] We develop a cell line for you
  • [H3] We ship you host cells and grant software access
  • [H3] You design DNA
  • [H3] We ship DNA to you
  • [H3] You perform cell line development
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We perform services in our lab
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request a stable cell line
  • [H3] We perform cell line and process development
  • [H3] We collaborate and share progress
  • [H3] We ship you clonal, stable cell lines
  • [H3] Everything you need
  • [H3] From our lab to yours
  • [H3] We use our own platform every day

Billeder

Vi fandt 285 billeder på denne side.

214 alt tags mangler eller er tomme. Tilføj alternativ tekst til dine billeder for at gøre siden mere brugervenlig, og for at optimere din SEO i forhold til søgemaskinerne.

Text/HTML balance

Balance : 11%

Denne sides text til HTML fordeling er under 15 procent, dette betyder at din side mangler indhold!

Flash

Perfekt, ingen Flash objekter er blevet fundet på siden.

iFrame

Beklager! Din side har iFrames og det kan medføre i yderst dårlig læsning af søgerobotterne.

URL Omskrivning

Godt. Dine links ser venlige ud!

Underscores i links

Perfekt! Ingen underscores blev fundet i dine links

On-page links

Vi fandt et total af 4 links inkluderende 0 link(s) til filer

Anker Type Juice
Biologics Intern Sender Juice
Cell Therapies Intern Sender Juice
Gene Therapies Intern Sender Juice
Sign up Intern Sender Juice

SEO Nøgleord

Nøgleords cloud

read design cells software development asimov blog cell line more

Nøgleords balance

Nøgleord Indhold Titel Nøgleord Beskrivelse Overskrifter
cell 113
more 86
asimov 85
read 79
line 79

Brugervenlighed

Link

Domæne : asimov.com

Længde : 10

FavIkon

Godt, din side har et FavIcon!

Printervenlighed

Vi kunne ikke finde en printer venlig CSS skabelon.

Sprog

Godt, dit tildelte sprog er en.

Dublin Core

Denne side benytter IKKE Dublin Core principperne.

Dokument

Dokumenttype

HTML 5

Kryptering

Perfekt. Dit Charset er tildelt UTF-8.

W3C Validering

Fejl : 0

Advarsler : 0

Email Privatliv

Advarsel! Mindst én email adresse er blevet fundet i rå tekst. Brug gratis antispam beskytter for at hemme din email fra spammere.

Udgået HTML

Godt! Vi har ikke fundet udgåede HTML tags i din kildekode

Hastigheds Tips

Alle tiders! Din webside bruger ikke nestede tabeller.
Advarsel! Din webside benytter inline CSS kode!
Godt, din website har få antal CSS filer
Dårligt, din webside har for mange JavaScript filer (mere end 6).
Perfekt, din hjemmeside udnytter gzip.

Mobil

Mobil Optimering

Apple Ikon
Meta Viewport Tag
Flash indhold

Optimering

XML Sitemap

Stor, din hjemmeside har en XML sitemap.

https://www.asimov.com/sitemap.xml

Robots.txt

https://asimov.com/robots.txt

Stor, din hjemmeside har en robots.txt-fil.

Analytics

Stor, din hjemmeside har et analyseværktøj.

   Google Analytics

PageSpeed Insights

Apparat
Kategorier

Free SEO Testing Tool

Free SEO Testing Tool er et gratis SEO redskab der hjælper med din hjemmeside